Nasometin (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasometin, is a corticosteroid presented as a nasal spray for nasal administration. It exerts potent anti‑inflammatory activity on the nasal mucosa and is indicated for the relief of symptoms associated with allergic rhinitis, including both seasonal and perennial types, in adult and pediatric patients.

GNH USA supplies Nasometin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is manufactured under GMP conditions, ensuring consistent potency and safety.

Nasometin (mometasone furoate) is a nasal corticosteroid used to manage inflammatory conditions of the nasal passages. - Allergic rhinitis: reduces nasal congestion, itching and sneezing associated with allergic rhinitis. - Seasonal allergic rhinitis: provides symptom relief during pollen seasons. - Perennial allergic rhinitis: controls year‑round allergic nasal symptoms.

Nasometin may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleeds) - Throat irritation

Serious or Rare Side Effects: - Nasal septal perforation - Vision changes or cataracts - Suppression of the hypothalamic‑pituitary‑adrenal axis

Before using Nasometin, consider the following precautions to ensure safe and effective therapy. - Assess for active infections: avoid use if nasal or sinus infection is present. - Monitor for glaucoma or cataract risk: inform ophthalmologist if long‑term use is planned. - Use with caution in children: follow pediatric dosing recommendations from prescriber. - Avoid abrupt discontinuation: taper under medical guidance to prevent rebound symptoms. - Review concomitant nasal medications: coordinate with healthcare provider to prevent additive effects. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Nasometin can interact with other medicines; awareness of these interactions helps minimize adverse outcomes.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of systemic glucocorticoid effects. - CYP3A4 inhibitors (e.g., ketoconazole): may raise local mometasone exposure.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance nasal dryness, monitor comfort. - Nasal decongestants: combined use can increase local irritation. - Antifungal nasal sprays: potential for additive local irritation.